PCV17 Cost-Effectiveness Analysis of Bosentan and Sildenafil Compared with Standard therapy in Treatment of Primary Pulmonary Arterial Hypertension in Russian Federation
Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.739
https://www.valueinhealthjournal.com/article/S1098-3015(11)02301-1/fulltext
Title :
PCV17 Cost-Effectiveness Analysis of Bosentan and Sildenafil Compared with Standard therapy in Treatment of Primary Pulmonary Arterial Hypertension in Russian Federation
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)02301-1&doi=10.1016/j.jval.2011.08.739
First page :
A367
Section Title :
Cardiovascular Disorders
Open access? :
No
Section Order :
705